DLL3-BB05
- Generic Name
- DLL3-BB05
A Study of FZ-AD005 in Patients With Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)
- Interventions
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2024-07-24
- Target Recruit Count
- 162
- Registration Number
- NCT06424665
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, Shanghai, China
🇨🇳Hunan Cancer Hospital, Changsha, Hunan, China
🇨🇳Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath